Publications by authors named "L BENDER"

Bacterial contamination of angiographic materials and fluids has been shown to occur during human angiographic procedures. Angiographic examinations and experiments must be performed under sterile conditions to avoid complications due to contamination and possible subsequent infections. However, data regarding the frequency and the clinical consequences are limited.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how serum biomarkers and substance use predict the conversion from major depressive disorder (MDD) to bipolar disorder (BD) in adults.
  • The conversion rate from MDD to BD was found to be 12.4%, with higher incidences among women and those with specific educational backgrounds and cocaine use.
  • The analysis indicated a notable interaction between nerve growth factor (NGF) levels and cocaine use, suggesting these factors may contribute to the diagnostic conversion and, if untreated, could lead to poorer outcomes in BD prognosis.
View Article and Find Full Text PDF

Background: Around 2-6% of term or late preterm neonates receive phototherapy for hyperbilirubinemia. Standard treatment today is overhead phototherapy. A new device has been developed, the BiliCocoon, where the neonates are "wrapped" presumably making them more comfortable.

View Article and Find Full Text PDF
Article Synopsis
  • Imlunestrant is a next-generation oral selective estrogen receptor degrader being tested in the EMBER trial for patients with ER+ advanced breast cancer and endometrioid endometrial cancer (EEC).
  • The trial involves a dose-escalation design to determine optimal doses and measure safety, pharmacokinetics, and anticancer effects, focusing specifically on patients who have already undergone certain previous treatments.
  • Results showed manageable side effects and some evidence of antitumor activity, with better outcomes observed when imlunestrant was combined with abemaciclib compared to imlunestrant alone.
View Article and Find Full Text PDF

Diffuse midline gliomas present a particularly intricate and challenging clinical scenario. This rare case involves a patient with comutant H3F3A and FGFR diffuse midline glioma with a clinical presentation of fulminant leptomeningitis. A 22-year-old male presented with fatal and fulminant diffuse leptomeningitis.

View Article and Find Full Text PDF